- Sulfonylurea type 2 diabetes drugs are linked to a higher long-term risk of an impaired awareness of hypoglycemic episodes, according to a new study from Taiwan.
- From 5 years of use onward, the study suggests that repeated hypoglycemic events de-sensitize sulfonylurea users to the occurrence of hypoglycemic symptoms.
- Impaired hypoglycemic awareness with sulfonylureas was compared with that of insulin use, which conversely tapered off with time.
Sulfonylureas, a class of type 2 diabetes…
Read the full article here